-
1
-
-
0028943130
-
2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys
-
2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys, Jpn. J. Pharmacol. 67, 117.
-
(1995)
Jpn. J. Pharmacol.
, vol.67
, pp. 117
-
-
Akai, T.1
Ozawa, M.2
Yamaguchi, M.3
Mizuta, E.4
Kuno, S.5
-
2
-
-
0020423353
-
Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively
-
Andén, N.-E., K. Golembiowska-Nikitin and U. Thornström, 1982, Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively, Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 100.
-
(1982)
Naunyn-Schmiedeberg's Arch. Pharmacol.
, vol.321
, pp. 100
-
-
Andén, N.-E.1
Golembiowska-Nikitin, K.2
Thornström, U.3
-
3
-
-
0020694507
-
Effects of B-HT 920 and B-HT 933 on dopamine and noradrenal autoreceptors in the rat brain
-
Andén, N.-E., H. Nilsson, E. Ros and U. Thornström, 1983, Effects of B-HT 920 and B-HT 933 on dopamine and noradrenal autoreceptors in the rat brain, Acta Pharmacol. Toxicol. 52, 51.
-
(1983)
Acta Pharmacol. Toxicol.
, vol.52
, pp. 51
-
-
Andén, N.-E.1
Nilsson, H.2
Ros, E.3
Thornström, U.4
-
4
-
-
0022589131
-
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
-
Bankiewicz, K.S., E.H. Oldfield, C.C. Chiueh, J.L. Doppman, D.M. Jacobowitz and I.J. Kopin, 1986, Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Life Sci. 39, 7.
-
(1986)
Life Sci.
, vol.39
, pp. 7
-
-
Bankiewicz, K.S.1
Oldfield, E.H.2
Chiueh, C.C.3
Doppman, J.L.4
Jacobowitz, D.M.5
Kopin, I.J.6
-
5
-
-
0342274140
-
2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinson's disease
-
in press
-
2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinson's disease, Brain Res. Bull. 42 (in press).
-
(1997)
Brain Res. Bull.
, vol.42
-
-
Domino, E.F.1
-
6
-
-
0027440486
-
2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys
-
2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys, J. Pharmacol. Exp. Ther. 264, 221.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.264
, pp. 221
-
-
Domino, E.F.1
Sheng, J.2
-
8
-
-
0343579378
-
2 agonists
-
Abstracts Michigan Chapter Soc. Neurosci., Ann Arbor, MI, May 12
-
2 agonists, p. 67. Abstracts Michigan Chapter Soc. Neurosci., 26th Annual Meeting, Ann Arbor, MI, May 12.
-
(1995)
26th Annual Meeting
, pp. 67
-
-
Georgic, L.M.1
Whetzel, S.Z.2
Cooke, L.W.3
Christoffersen, C.L.4
Serpa, K.A.5
Van Leeuwen, D.H.6
MacKenzie, R.G.7
Davis, M.D.8
Pugsley, T.A.9
Meltzer, L.T.10
Heffner, T.G.11
-
9
-
-
0023020113
-
The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: A novel approach to treatment
-
Hinzen, D., O. Hornykiewicz, W. Kobinger, L. Pichler, C. Pifl and G. Schingnitz, 1986, The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment, Eur. J. Pharmacol. 131, 75.
-
(1986)
Eur. J. Pharmacol.
, vol.131
, pp. 75
-
-
Hinzen, D.1
Hornykiewicz, O.2
Kobinger, W.3
Pichler, L.4
Pifl, C.5
Schingnitz, G.6
-
10
-
-
0343579377
-
#33 Electrophysiological evidence associating limbic preference with pramipexole, a D3-preferring dopamine agonist
-
Abstracts Michigan Chapter Soc. Neurosci., Ann Arbor, MI, May 12
-
Hoffmann, W.E., M.W. Smith and M.F. Piercey, 1995, #33 Electrophysiological evidence associating limbic preference with pramipexole, a D3-preferring dopamine agonist, p. 70. Abstracts Michigan Chapter Soc. Neurosci., 26th Annual Meeting, Ann Arbor, MI, May 12.
-
(1995)
26th Annual Meeting
, pp. 70
-
-
Hoffmann, W.E.1
Smith, M.W.2
Piercey, M.F.3
-
11
-
-
0027743607
-
The toxicology of talipexole in rats
-
Honma, M., A. Matsuo, T. Yabe, J. Nishikawa, Y. Tsunenari, A. Kast and K. Kohei, 1993, The toxicology of talipexole in rats, Oyo Yakuri/Pharmacometrics 46, 383.
-
(1993)
Oyo Yakuri/Pharmacometrics
, vol.46
, pp. 383
-
-
Honma, M.1
Matsuo, A.2
Yabe, T.3
Nishikawa, J.4
Tsunenari, Y.5
Kast, A.6
Kohei, K.7
-
12
-
-
0027773176
-
2) in cynomolgus monkeys
-
2) in cynomolgus monkeys, Oyo Yakuri/Pharmacometrics 46, 401.
-
(1993)
Oyo Yakuri/Pharmacometrics
, vol.46
, pp. 401
-
-
Ihara, T.1
Funato, M.2
Chihaya, Y.3
Honda, T.4
Nagata, R.5
Honma, M.6
-
13
-
-
0027234091
-
Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets
-
Irifune, M., M. Nomoto and T. Fukuda, 1993, Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets, Eur. J. Pharmacol. 238, 235.
-
(1993)
Eur. J. Pharmacol.
, vol.238
, pp. 235
-
-
Irifune, M.1
Nomoto, M.2
Fukuda, T.3
-
14
-
-
0027949076
-
Antiparkinsonian activity of talipexole in MPTP-treated monkeys: In combination with L-DOPA and as chronic treatment
-
Irifune, M., M. Nomoto and T. Fukuda, 1994, Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-DOPA and as chronic treatment, Eur. J. Pharmacol. 264, 117.
-
(1994)
Eur. J. Pharmacol.
, vol.264
, pp. 117
-
-
Irifune, M.1
Nomoto, M.2
Fukuda, T.3
-
15
-
-
0027186688
-
The oral toxicology of talipexole in rhesus monkeys
-
Kast, A., H. Ganz and W. Frölke, 1993, The oral toxicology of talipexole in rhesus monkeys, Oyo Yakuri/Pharmacometrics 45, 545.
-
(1993)
Oyo Yakuri/Pharmacometrics
, vol.45
, pp. 545
-
-
Kast, A.1
Ganz, H.2
Frölke, W.3
-
16
-
-
0019439340
-
2-adrenoceptor subtypes: Selectivity of various agonists and relative distribution of receptors as determined in rats
-
2-adrenoceptor subtypes: selectivity of various agonists and relative distribution of receptors as determined in rats, Eur. J. Pharmacol. 73, 313.
-
(1981)
Eur. J. Pharmacol.
, vol.73
, pp. 313
-
-
Kobinger, W.1
Pichler, L.2
-
17
-
-
0030471228
-
The effects of talipexole on central monoamine receptors and metabolism in rats, with special reference to its effects on dopaminergic systems
-
Jpn.
-
Kohno, Y., Y. Kitamura, M. Nakazawa and Y. Nomura, 1996a, The effects of talipexole on central monoamine receptors and metabolism in rats, with special reference to its effects on dopaminergic systems, Pharmacometrics (Jpn.) 52, 233.
-
(1996)
Pharmacometrics
, vol.52
, pp. 233
-
-
Kohno, Y.1
Kitamura, Y.2
Nakazawa, M.3
Nomura, Y.4
-
18
-
-
0029990191
-
Electroencephalographic study on sedative effects of talipexole, a novel antiparkinsonian drug, in rats with chronic electrode implants
-
Jpn.
-
Kohno, Y., S. Shibata, M. Ohno and S. Watanabe, 1996b, Electroencephalographic study on sedative effects of talipexole, a novel antiparkinsonian drug, in rats with chronic electrode implants, Pharmacometrics (Jpn.) 51, 45.
-
(1996)
Pharmacometrics
, vol.51
, pp. 45
-
-
Kohno, Y.1
Shibata, S.2
Ohno, M.3
Watanabe, S.4
-
19
-
-
0031014879
-
2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum
-
2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum, Eur. J. Pharmacol. 319, 197.
-
(1997)
Eur. J. Pharmacol.
, vol.319
, pp. 197
-
-
Kohno, Y.1
Fukuzaki, K.2
Kitahara, K.3
Koja, T.4
-
21
-
-
0029094038
-
Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons
-
Matsubayashi, H., T. Amano, Y. Hongjing, Y. Kohno and M. Sasa, 1995, Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons, Psychopharmacology 120, 369.
-
(1995)
Psychopharmacology
, vol.120
, pp. 369
-
-
Matsubayashi, H.1
Amano, T.2
Hongjing, Y.3
Kohno, Y.4
Sasa, M.5
-
22
-
-
0029006499
-
Pramipexole: A dopamine-receptor agonist for treatment of Parkinson's disease
-
Mierau, J., 1995, Pramipexole: a dopamine-receptor agonist for treatment of Parkinson's disease, Clin. Neuropharmacol. 18 (Suppl. 1), S195.
-
(1995)
Clin. Neuropharmacol.
, vol.18
, Issue.1 SUPPL.
-
-
Mierau, J.1
-
24
-
-
0028979076
-
4 receptors
-
4 receptors, Eur. J. Pharmacol. 290, 29.
-
(1995)
Eur. J. Pharmacol.
, vol.290
, pp. 29
-
-
Mierau, J.1
Schneider, F.J.2
Ensinger, H.A.3
Chio, C.L.4
Lajines, M.E.5
Huff, R.M.6
-
25
-
-
0024586654
-
The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: Two directions of D-1:D-2 interaction
-
Murray, A.M. and J.L. Waddington, 1989, The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction, Eur. J. Pharmacol. 160, 377.
-
(1989)
Eur. J. Pharmacol.
, vol.160
, pp. 377
-
-
Murray, A.M.1
Waddington, J.L.2
-
26
-
-
0000704640
-
The clinical evaluation of B-HT 920 (talipexole hydrochloride) in Parkinson's disease
-
Nakanisi, T., H. Kowa, Y. Mizuno and N. Yanagisawa, 1993, The clinical evaluation of B-HT 920 (talipexole hydrochloride) in Parkinson's disease, Clin. Eval. 21, 59.
-
(1993)
Clin. Eval.
, vol.21
, pp. 59
-
-
Nakanisi, T.1
Kowa, H.2
Mizuno, Y.3
Yanagisawa, N.4
-
27
-
-
0030178758
-
3 receptor blocking properties of the antiparkinsonian agent, talipexole
-
3 receptor blocking properties of the antiparkinsonian agent, talipexole, Gen. Pharmacol. 27, 779.
-
(1996)
Gen. Pharmacol.
, vol.27
, pp. 779
-
-
Nishio, H.1
Kohno, Y.2
Fujii, A.3
Negishi, Y.4
Inoue, A.5
Nakata, Y.6
-
28
-
-
0021891425
-
1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset
-
1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset, Neurosci. Lett. 57, 37.
-
(1985)
Neurosci. Lett.
, vol.57
, pp. 37
-
-
Nomoto, M.1
Jenner, P.2
Marsden, C.D.3
-
30
-
-
0024521447
-
Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor
-
O'Boyle, K.M., D.E. Gaitanopoulos, M. Brenner and J.L. Waddington, 1989, Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor, Neuropharmacology 28, 401.
-
(1989)
Neuropharmacology
, vol.28
, pp. 401
-
-
O'Boyle, K.M.1
Gaitanopoulos, D.E.2
Brenner, M.3
Waddington, J.L.4
-
31
-
-
0019976120
-
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1 H-3-benzazepines
-
Pfeiffer, F.R., J.W. Wilson, J. Weinstock, G.Y. Kuo, P.A. Chambers, K.G. Holden, R.A. Hahn, J.R. Wardell Jr., A.J. Tobia, P.E. Setler and H.M. Sarau, 1982, Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1 H-3-benzazepines, J. Med. Chem. 25, 352.
-
(1982)
J. Med. Chem.
, vol.25
, pp. 352
-
-
Pfeiffer, F.R.1
Wilson, J.W.2
Weinstock, J.3
Kuo, G.Y.4
Chambers, P.A.5
Holden, K.G.6
Hahn, R.A.7
Wardell J.R., Jr.8
Tobia, A.J.9
Setler, P.E.10
Sarau, H.M.11
-
32
-
-
0019476290
-
Centrally mediated cardiovascular effects of B-HT 960 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo- [4,5-d]-azepin dihydrochloride) a hypertensive agent of the 'clonidine type'
-
Pichler, L. and W. Kobinger, 1981, Centrally mediated cardiovascular effects of B-HT 960 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo- [4,5-d]-azepin dihydrochloride) a hypertensive agent of the 'clonidine type', J. Cardiovasc. Pharmacol. 3, 269.
-
(1981)
J. Cardiovasc. Pharmacol.
, vol.3
, pp. 269
-
-
Pichler, L.1
Kobinger, W.2
-
33
-
-
0003633755
-
-
Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication #86-23, Superintendent of Documents, U.S. Government Printing Office, Washington, DC (Revised)
-
The Guide for the Care and Use of Laboratory Animals, 1985, Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council, pp. 1-83, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication #86-23, Superintendent of Documents, U.S. Government Printing Office, Washington, DC (Revised).
-
(1985)
The Guide for the Care and use of Laboratory Animals
, pp. 1-83
-
-
-
34
-
-
0023941360
-
Guidelines for prevention of herpes virus simiae (B virus) infection in monkey handlers
-
The Virus Working Group, 1988, Guidelines for prevention of herpes virus simiae (B virus) infection in monkey handlers, J. Med. Primatol. 17, 77.
-
(1988)
J. Med. Primatol.
, vol.17
, pp. 77
-
-
-
35
-
-
0028201688
-
2 agonist, of caudate nucleus neurons activated by nigral stimulation
-
2 agonist, of caudate nucleus neurons activated by nigral stimulation, Life Sci. 54, 957.
-
(1994)
Life Sci.
, vol.54
, pp. 957
-
-
Todo, N.1
Momiyama, T.2
Amano, T.3
Kohno, Y.4
Sasa, M.5
-
37
-
-
0027335571
-
1 agonist, SKF 81,297, stimulates motor behaviour of MPTP lesioned monkeys
-
1 agonist, SKF 81,297, stimulates motor behaviour of MPTP lesioned monkeys, Eur. J. Pharmacol. 235, 143.
-
(1993)
Eur. J. Pharmacol.
, vol.235
, pp. 143
-
-
Vermeulen, R.J.1
Drukarch, B.2
Shadat, M.C.R.3
Goosen, C.4
Wolters, E.Ch.5
Stoof, J.C.6
-
38
-
-
0025064086
-
Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats
-
Yamada, K., M. Nagashima, H. Kimura, S. Matsumoto and T. Furukawa, 1990, Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats, Psychopharmacology 100, 141.
-
(1990)
Psychopharmacology
, vol.100
, pp. 141
-
-
Yamada, K.1
Nagashima, M.2
Kimura, H.3
Matsumoto, S.4
Furukawa, T.5
|